Paul Critser

Title: The Innovations of Paul Critser

Introduction

Paul Critser is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biomedical engineering, particularly in the area of vascular biology. With a total of two patents to his name, Critser's work focuses on innovative materials and methods that enhance the understanding and application of vasculogenesis.

Latest Patents

Critser's latest patents include "Materials and methods for controlling vasculogenesis from endothelial colony forming cells." This patent discloses methods for controlling vasculogenesis using building blocks of a collagen matrix and endothelial colony forming cells (ECFC). The building blocks can be isolated by fractionating an acid-soluble Type I collagen. These building blocks, comprising monomers and/or oligomers, can be recombined in desired ratios to alter the matrix microenvironment and influence ECFC behavior. Another notable patent is "Collagen-based matrices with stem cells." This patent describes collagen-based matrices and methods for differentiating stem cells and progenitor cells, as well as for producing and isolating blood vessels and vascularized graft constructs.

Career Highlights

Throughout his career, Critser has worked with prestigious institutions such as Indiana University and Purdue Research Foundation. His research has significantly advanced the understanding of vascular development and tissue engineering.

Collaborations

Critser has collaborated with notable colleagues, including Sherry L. Voytik-Harbin and Mervin C. Yoder. Their combined expertise has contributed to the success of various research projects and innovations in the field.

Conclusion

Paul Critser's innovative work in the field of vascular biology and tissue engineering has led to significant advancements in the understanding of vasculogenesis. His patents reflect a commitment to improving biomedical applications and enhancing the potential for future medical treatments.